Oliclinomel N 4-550e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Oliclinomel N 4-550e provides a broad spectrum amino‑acid formulation that supports patients with metabolic and nutritional needs in several clinical contexts:

• Critical care: helps to maintain nitrogen balance and supports protein synthesis during intensive‑care treatment.
• Peri‑operative care: contributes to tissue repair and wound healing during the surgical period.
• Metabolic disorders: supplies essential amino acids for patients with inborn errors of metabolism or catabolic states.
• Long‑term parenteral nutrition: serves as a component of total parenteral nutrition regimens for patients unable to receive enteral feeding.

• The amino‑acid blend supplies the building blocks required for protein synthesis, stimulates the mTOR signaling pathway and provides substrates for gluconeogenesis and nitrogen transport. By delivering essential and conditionally essential amino acids directly into the bloodstream, the formulation helps restore plasma amino‑acid concentrations, supports cellular metabolism and promotes anabolic processes needed for tissue repair and immune function.

Amino‑acid solutions administered intravenously can be associated with a range of reactions, most of which are mild and transient.

Common Side Effects

• Phlebitis at the infusion site: mild inflammation of the vein.
• Transient hyperglycaemia: temporary rise in blood glucose levels.
• Mild electrolyte imbalance: slight changes in serum potassium or calcium.
• Nausea or mild gastrointestinal discomfort.
• Low‑grade fever: mild increase in body temperature.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergy requiring immediate medical intervention.
• Metabolic acidosis: significant shift in acid‑base balance.
• Hyperosmolarity‑related complications: circulatory overload or renal strain.
• Severe electrolyte disturbances: marked hyper‑ or hypokalemia.
• Sepsis related to catheter contamination.
• Acute liver dysfunction in susceptible patients.

When using Oliclinomel N 4-550e, clinicians should observe several safety measures:

• Renal function monitoring: assess creatinine and urine output regularly.
• Hepatic function monitoring: check liver enzymes and bilirubin levels.
• Blood glucose monitoring: watch for hyperglycaemia, especially in diabetic patients.
• Electrolyte surveillance: maintain serum potassium, calcium and magnesium within target ranges.
• Infusion rate control: administer according to recommended flow rates to avoid osmotic stress.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

• Oliclinomel N 4‑550e may interact with other intravenous solutions and medications administered through the same line.
• Major Interactions (Avoid):
• -    ​  Electrolyte‑    ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​  ​  ​  ​
• -  L  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​
• -  C ​
• -  D
• -  E
• Moderate Interactions (Monitor Closely):
• -    ​  ​  C ​  ​  ​  ​
• -    
• -   
• d 
• t 
• t
• t
• """"    " "" "